The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19
Autor: | Gottlieb, Robert L., Clement, Meredith, Cook, Paul, Deveikis, Audra, Foong, Kap Sum, Robinson, Philip, Slim, Jihad, Spak, Cedric W., Buelens, Annemie, Callewaert, Katleen, De Meyer, Sandra, Mo, Wai Ling, Verbrugge, Inge, Van Wesenbeeck, Liesbeth, Zhuang, Yanli, Chien, Jason W., Opsomer, Magda, Van Landuyt, Erika |
---|---|
Zdroj: | In Journal of Infection October 2024 89(4) |
Databáze: | ScienceDirect |
Externí odkaz: |